Quest Diagnostics Incorporated will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Chairman, CEO and President Jim Davis, along with Executive Vice President and CFO Sam Samad, will speak about the company's strategy, performance, and recent market trends during a presentation and Q&A session on Monday, January 12, 2026, at 4:30 p.m. Pacific Time. The session will be webcast live and available for replay on the company's investor relations website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quest Diagnostics Incorporated published the original content used to generate this news brief on December 19, 2025, and is solely responsible for the information contained therein.
Comments